Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: Innate protection against infection by Candida albicans

Glycobiology

Volumn 22, Issue 11, 2012, Pages 1465-1479

  Everest Dass, Arun V ^a   Jin, Dayong ^a   Thaysen Andersen, Morten ^a   Nevalainen, Helena ^a   Kolarich, Daniel ^a,b   Packer, Nicolle H ^a  

^a MACQUARIE UNIVERSITY   (Australia)

^b MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

Author keywords

buccal epithelial cells; decoy; glycomics; mass spectrometry; saliva

Indexed keywords

CELL MEMBRANE PROTEIN; EPITOPE; GLYCAN; GLYCOPROTEIN; MANNOSE; OLIGOSACCHARIDE; PAUCIMANNOSE GLYCAN; SALIVA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP LEWIS SYSTEM; CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; CELL MEMBRANE; CHEEK; ELECTROSPRAY MASS SPECTROMETRY; FLOW CYTOMETRY; GLYCOSYLATION; HUMAN; HUMAN CELL; INNATE IMMUNITY; LIQUID CHROMATOGRAPHY; MOUTH MUCOSA; NONHUMAN; PRIORITY JOURNAL; SALIVA; SIALYLATION;

CANDIDA ALBICANS; GLYCOMICS; GLYCOSYLATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MEMBRANE GLYCOPROTEINS; MOUTH MUCOSA; POLYSACCHARIDES; PROTEOMICS; SALIVARY PROTEINS AND PEPTIDES;

CANDIDA ALBICANS; FUNGI;

EID: 84868035982     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws112     Document Type: Article

References (75)

1. Aguirre A, Mendoza B, Reddy MS, Scannapieco FA, Levine MJ, Hatton MN. 1989. Lubrication of selected salivary molecules and artificial salivas. Dysphagia. 4:95-100.
2. Amado FML, Vitorino RMP, Lobo MJC, Domingues PMDN. 2007. Proteomics of Human Saliva. Totowa, NJ: Humana Press. p. 347-376.
3. Amerongen AV, Veerman EC. 2002. Saliva-the defender of the oral cavity. Oral Dis. 8:12-22.
4. Beachey EH, Giampapa CS, Abraham SN. 1988. Bacterial adherence. Adhesin receptor-mediated attachment of pathogenic bacteria to mucosal surfaces. Am Rev Respir Dis. 138:S45-S48.
5. Brassart D, Woltz A, Golliard M, Neeser JR. 1991. In vitro inhibition of adhesion of Candida albicans clinical isolates to human buccal epithelial cells by Fuc alpha 1-2Gal beta-bearing complex carbohydrates. Infect Immun. 59:1605-1613.
6. Bronner-Fraser M. 1985. Alterations in neural crest migration by a monoclonal antibody that affects cell adhesion. J Cell Biol. 101:610-617.
7. Burford-Mason AP, Weber JC, Willoughby JM. 1988. Oral carriage of Candida albicans, ABO blood group and secretor status in healthy subjects. J Med Vet Mycol. 26:49-56.
8. Cameron BJ, Douglas LJ. 1996. Blood group glycolipids as epithelial cell receptors for Candida albicans. Infect Immun. 64:891-896.
9. Cannon RD, Chaffin WL. 1999. Oral colonization by Candida albicans. Crit Rev Oral Biol Med. 10:359-383.
10. Cannon RD, Nand AK, Jenkinson HF. 1995. Adherence of Candida albicans to human salivary components adsorbed to hydroxylapatite. Microbiology. 141(Pt 1):213-219.
11. Critchley IA, Douglas LJ. 1987. Role of glycosides as epithelial cell receptors for Candida albicans. J Gen Microbiol. 133:637-643.
12. Crottet P, Corthesy B. 1998. Secretory component delays the conversion of secretory IgA into antigen-binding competent F(ab')2: a possible implication for mucosal defense. J Immunol. 161:5445-5453.
13. Dabelsteen E. 2002. ABO blood group antigens in oral mucosa. What is new? J Oral Pathol Med. 31:65-70.
14. de Repentigny L, Aumont F, Bernard K, Belhumeur P. 2000. Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells. Infect Immun. 68:3172-3179.
15. Donohue DS, Ielasi FS, Goossens KV, Willaert RG. 2011. The N-terminal part of Als1 protein from Candida albicans specifically binds fucosecontaining glycans. Mol Microbiol. 80:1667-1679.
16. Frohm Nilsson M, Sandstedt B, Sorensen O, Weber G, Borregaard N, Stahle-Backdahl M. 1999. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun. 67:2561-2566.
17. Fukazawa Y, Kagaya K. 1997. Molecular bases of adhesion of Candida albicans. J Med Vet Mycol. 35:87-99.
18. Gagneux P, Varki A. 1999. Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology. 9:747-755.
19. Guile GR, Harvey DJ, O'Donnell N, Powell AK, Hunter AP, Zamze S, Fernandes DL, Dwek RA, Wing DR. 1998. Identification of highly fucosylated N-linked oligosaccharides from the human parotid gland. Eur J Biochem. 258:623-656.
20. Harvey DJ. 2005. Fragmentation of negative ions from carbohydrates: part 3. Fragmentation of hybrid and complex N-linked glycans. J Am Soc Mass Spectrom. 16:647-659.
21. Harvey DJ, Dwek RA, Rudd PM. 2006. Determining the structure of glycan moieties by mass spectrometry. Curr Protoc Protein Sci. Chapter 12:Unit 12.7.1-12.7.18.
22. Harvey DJ, Royle L, Radcliffe CM, Rudd PM, Dwek RA. 2008. Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry. Anal Biochem. 376:44-60.
23. Helmerhorst EJ, Oppenheim FG. 2007. Saliva: a dynamic proteome. J Dent Res. 86:680-693.
24. Hodgkin PD, Lee JH, Lyons AB. 1996. B cell differentiation and isotype switching is related to division cycle number. J Exp Med. 184:277-281.
25. Hoffman MP, Haidaris CG. 1993. Analysis of Candida albicans adhesion to salivary mucin. Infect Immun. 61:1940-1949.
26. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, Berg DE, Covacci A, Engstrand L, Boren T. 1998. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science. 279:373-377.
27. Issa S, Moran AP, Ustinov SN, Lin JH, Ligtenberg AJ, Karlsson NG. 2010. O-linked oligosaccharides from salivary agglutinin: Helicobacter pylori binding sialyl-Lewis x and Lewis b are terminating moieties on hyperfucosylated oligo-N-acetyllactosamine. Glycobiology. 20:1046-1057.
28. Ito H, Yamada K, Deguchi K, Nakagawa H, Nishimura S. 2007. Structural assignment of disialylated biantennary N-glycan isomers derivatized with 2-aminopyridine using negative-ion multistage tandem mass spectral matching. Rapid Commun Mass Spectrom. 21:212-218.
29. Johansson I, Bratt P, Hay DI, Schluckebier S, Stromberg N. 2000. Adhesion of Candida albicans, but not Candida krusei, to salivary statherin and mimicking host molecules. Oral Microbiol Immunol. 15:112-118.
30. Karlsson NG, Schulz BL, Packer NH. 2004. Structural determination of neutral O-linked oligosaccharide alditols by negative ion LCelectrospray-MSn. J Am Soc Mass Spectrom. 15:659-672.
31. Karlsson NG, Thomsson KA. 2009. Salivary MUC7 is a major carrier of blood group I type O-linked oligosaccharides serving as the scaffold for sialyl Lewis x. Glycobiology. 19:288-300.
32. Lamont RJ, Jenkinson HF. 2010. Oral microbiology at a glance. Chichester, West Sussex, UK, Ames, Iowa: Wiley-Blackwell.
33. Lawrence CW, Little PA, Little BW, Glushka J, van Halbeek H, Alhadeff JA. 1993. Human non-secretory ribonucleases. II. Structural characterization of the N-glycans of the kidney, liver and spleen enzymes by NMR spectroscopy and electrospray mass spectrometry. Glycobiology. 3:249-259.
34. Lee A, Chick JM, Kolarich D, Haynes PA, Robertson GR, Tsoli M, Jankova L, Clarke SJ, Packer NH, Baker MS. 2011. Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor. Mol Cell Proteomics. 10:M900538MCP900200.
35. Lee A, Kolarich D, Haynes PA, Jensen PH, Baker MS, Packer NH. 2009. Rat liver membrane glycoproteome: enrichment by phase partitioning and glycoprotein capture. J Proteome Res. 8:770-781.
36. Levine MJ, Reddy MS, Tabak LA, Loomis RE, Bergey EJ, Jones PC, Cohen RE, Stinson MW, Al-Hashimi I. 1987. Structural aspects of salivary glycoproteins. J Dent Res. 66:436-441.
37. Lowe JB, Marth JD. 2003. A genetic approach to mammalian glycan function. Annu Rev Biochem. 72:643-691.
38. Mandel ID. 1987. The functions of saliva. J Dent Res. 66(Spec No):623-627.
39. Mulvey G, Kitov PI, Marcato P, Bundle DR, Armstrong GD. 2001. Glycan mimicry as a basis for novel anti-infective drugs. Biochimie. 83:841-847.
40. Nakano M, Saldanha R, Gobel A, Kavallaris M, Packer NH. 2011. Identification of glycan structure alterations on cell membrane proteins in desoxyepothilone B resistant leukemia cells. Mol Cell Proteomics. 10: M111009001.
41. Natsuka S. 2005. Comparative biochemical view of N-glycans. Trends in Glycoscience and Glycotechnology. 17:229-236.
42. Navas EL, Venegas MF, Duncan JL, Anderson BE, Chmiel JS, Schaeffer AJ. 1993. Blood group antigen expression on vaginal and buccal epithelial cells and mucus in secretor and nonsecretor women. J Urol. 149:1492-1498.
43. Newburg DS, Ruiz-Palacios GM, Morrow AL. 2005. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr. 25:37-58.
44. Ofek I, Kahane I, Sharon N. 1996. Toward anti-adhesion therapy for microbial diseases. Trends Microbiol. 4:297-299.
45. Offner GD, Troxler RF. 2000. Heterogeneity of high-molecular-weight human salivary mucins. Adv Dent Res. 14:69-75.
46. Osswald K, Mittas A, Glei M, Pool-Zobel BL. 2003. New revival of an old biomarker: characterisation of buccal cells and determination of genetic damage in the isolated fraction of viable leucocytes. Mutat Res. 544:321-329.
47. O'Sullivan JM, Cannon RD, Sullivan PA, Jenkinson HF. 1997. Identification of salivary basic proline-rich proteins as receptors for Candida albicans adhesion. Microbiology. 143(Pt 2):341-348.
48. Overbye KM, Barrett JF. 2005. Antibiotics: where did we go wrong? Drug Discov Today. 10:45-52.
49. Pabst M, Bondili JS, Stadlmann J, Mach L, Altmann F. 2007. Mass + retention time = structure: a strategy for the analysis of N-glycans by carbon LC-ESI-MS and its application to fibrin N-glycans. Anal Chem. 79:5051-5057.
50. Packer NH, Lawson MA, Jardine DR, Redmond JW. 1998. A general approach to desalting oligosaccharides released from glycoproteins. Glycoconj J. 15:737-747.
51. Parente F, Cucino C, Anderloni A, Grandinetti G, Bianchi Porro G. 2003. Treatment of Helicobacter pylori infection using a novel antiadhesion compound (3′sialyllactose sodium salt). A double blind, placebo-controlled clinical study. Helicobacter. 8:252-256.
52. Perrier C, Sprenger N, Corthesy B. 2006. Glycans on secretory component participate in innate protection against mucosal pathogens. J Biol Chem. 281:14280-14287.
53. Prakobphol A, Leffler H, Fisher SJ. 1993. The high-molecular-weight human mucin is the primary salivary carrier of ABH, Le(a), and Le(b) blood group antigens. Crit Rev Oral Biol Med. 4:325-333.
54. Prakobphol A, Tangemann K, Rosen SD, Hoover CI, Leffler H, Fisher SJ. 1999. Separate oligosaccharide determinants mediate interactions of the low-molecular-weight salivary mucin with neutrophils and bacteria. Biochemistry. 38:6817-6825.
55. Prakobphol A, Thomsson KA, Hansson GC, Rosen SD, Singer MS, Phillips NJ, Medzihradszky KF, Burlingame AL, Leffler H, Fisher SJ. 1998. Human low-molecular-weight salivary mucin expresses the sialyl lewisx determinant and has L-selectin ligand activity. Biochemistry. 37:4916-4927.
56. Robbe C, Michalski JC, Capon C. 2006. Structural determination of O-glycans by tandem mass spectrometry. Methods Mol Biol. 347:109-123.
57. Royle L, Roos A, Harvey DJ, Wormald MR, van Gijlswijk-Janssen D, Redwan el RM, Wilson IA, Daha MR, Dwek RA, Rudd PM. 2003. Secretory IgA N-and O-glycans provide a link between the innate and adaptive immune systems. J Biol Chem. 278:20140-20153.
58. Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS. 2003. Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem. 278:14112-14120.
59. Satomaa T, Heiskanen A, Mikkola M, Olsson C, Blomqvist M, Tiittanen M, Jaatinen T, Aitio O, Olonen A, Helin J, et al. 2009. The N-glycome of human embryonic stem cells. BMC Cell Biol. 10:42-60.
60. Schulz BL, Oxley D, Packer NH, Karlsson NG. 2002. Identification of two highly sialylated human tear-fluid DMBT1 isoforms: the major high-molecular-mass glycoproteins in human tears. Biochem J. 366:511-520.
61. Seymour JL, Costello CE, Zaia J. 2006. The influence of sialylation on glycan negative ion dissociation and energetics. J Am Soc Mass Spectrom. 17:844-854.
62. Sharon N. 2006. Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochim Biophys Acta. 1760:527-537.
63. Shin ES, Chung SC, Kim YK, Lee SW, Kho HS. 2003. The relationship between oral Candida carriage and the secretor status of blood group antigens in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 96:48-53.
64. Slomiany BL, Murty VL, Slomiany A. 1993. Structural features of carbohydrate chains in human salivary mucins. Int J Biochem. 25:259-265.
65. Thomsson KA, Prakobphol A, Leffler H, Reddy MS, Levine MJ, Fisher SJ, Hansson GC. 2002. The salivary mucin MG1 (MUC5B) carries a repertoire of unique oligosaccharides that is large and diverse. Glycobiology. 12:1-14.
66. Thomsson KA, Schulz BL, Packer NH, Karlsson NG. 2005. MUC5B glycosylation in human saliva reflects blood group and secretor status. Glycobiology. 15:791-804.
67. Thongboonkerd V. 2007. Proteomics of Human Body Fluids Principles, Methods, and Applications. Totowa, NJ: Humana Press Inc.
68. Ukkonen P, Varis K, Jernfors M, Herva E, Jokinen J, Ruokokoski E, Zopf D, Kilpi T. 2000. Treatment of acute otitis media with an antiadhesive oligosaccharide: a randomised, double-blind, placebo-controlled trial. Lancet. 356:1398-1402.
69. Varki A. 2006. Nothing in glycobiology makes sense, except in the light of evolution. Cell. 126:841-845.
70. Wilson NL, Schulz BL, Karlsson NG, Packer NH. 2002. Sequential analysis of N-and O-linked glycosylation of 2D-PAGE separated glycoproteins. J Proteome Res. 1:521-529.
71. Xie H, Onsongo G, Popko J, de Jong EP, Cao J, Carlis JV, Griffin RJ, Rhodus NL, Griffin TJ. 2008. Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol Cell Proteomics. 7:486-498.
72. Yu L, Lee KK, Sheth HB, Lane-Bell P, Srivastava G, Hindsgaul O, Paranchych W, Hodges RS, Irvin RT. 1994. Fimbria-mediated adherence of Candida albicans to glycosphingolipid receptors on human buccal epithelial cells. Infect Immun. 62:2843-2848.
73. Zalewska A, Zwierz K, Zolkowski K, Gindzienski A. 2000. Structure and biosynthesis of human salivary mucins. Acta Biochim Pol. 47:1067-1079.
74. Zheng T, Jiang H, Gros M, del Amo DS, Sundaram S, Lauvau G, Marlow F, Liu Y, Stanley P, Wu P. 2011. Tracking N-acetyllactosamine on cell-surface glycans in vivo. Angew Chem Int Ed Engl. 50:4113-4118.
75. Zopf D, Roth S. 1996. Oligosaccharide anti-infective agents. Lancet. 347:1017-1021.